Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ·Healthcare·Biotechnology
$34.47
-2.09%
Mkt Cap $2.05B
Analyst Ratings
Buy
3
Hold
3
Sell
1
Price Target (19 analysts)
$46.80
Range $31.00 – $62.00
Implied Upside
+35.8%
Consensus $46.80 vs current $34.47